How to demonstrate the clinical implication of prophylactic implantable cardioverter-defibrillator in patients with advanced light chain amyloidosis
- PMID: 40421168
- PMCID: PMC12104819
- DOI: 10.1002/joa3.70099
How to demonstrate the clinical implication of prophylactic implantable cardioverter-defibrillator in patients with advanced light chain amyloidosis
Keywords: atrial fibrillation; cardiac amyloidosis; heart failure; ventricular tachyarrhythmia.
Conflict of interest statement
Authors declare no conflict of interests for this article.
Similar articles
-
Prophylactic implantation of cardioverter-defibrillator in patients with advanced light-chain amyloidosis-A pilot study.J Arrhythm. 2025 Apr 20;41(2):e70068. doi: 10.1002/joa3.70068. eCollection 2025 Apr. J Arrhythm. 2025. PMID: 40256665 Free PMC article.
-
Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.Heart Rhythm. 2014 Jan;11(1):158-62. doi: 10.1016/j.hrthm.2013.10.026. Epub 2013 Oct 10. Heart Rhythm. 2014. PMID: 24121001 No abstract available.
-
Impact of the implantable cardioverter-defibrillator on rehospitalizations.Eur Heart J. 1996 Oct;17(10):1565-71. doi: 10.1093/oxfordjournals.eurheartj.a014722. Eur Heart J. 1996. PMID: 8909915
-
Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review.JACC CardioOncol. 2021 Oct 19;3(4):506-515. doi: 10.1016/j.jaccao.2021.07.010. eCollection 2021 Oct. JACC CardioOncol. 2021. PMID: 34729522 Free PMC article. Review.
-
Prevalence of ventricular arrhythmias and role of implantable cardioverter-defibrillator in cardiac amyloidosis.J Cardiol. 2023 May;81(5):429-433. doi: 10.1016/j.jjcc.2023.02.009. Epub 2023 Mar 7. J Cardiol. 2023. PMID: 36894119 Review.
References
Publication types
LinkOut - more resources
Full Text Sources